We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+9.76%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$92.1M
(+7.6%)
Cap. Flow
+$25M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
36.27%
Holding
543
New
63
Increased
193
Reduced
214
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Gold
UGL
|
+$16.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$6.26M |
| 3 |
Micron Technology
MU
|
+$4.07M |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.94M |
| 5 |
Ferrari
RACE
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$11.5M |
| 2 |
iShares Silver Trust
SLV
|
+$7.75M |
| 3 |
Amazon
AMZN
|
+$6.78M |
| 4 |
Oracle
ORCL
|
+$2.75M |
| 5 |
Royal Caribbean
RCL
|
+$2.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.86% |
| 2 | Healthcare | 22.63% |
| 3 | Communication Services | 13.04% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Consumer Staples | 2.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Allogene Therapeutics
ALLO
$714M
| $50.2K | ﹤0.01% |
36,620
-2,272
| -6% | -$3K |
|
452
Lifecore Biomedical
LFCR
$181M
| $49.9K | ﹤0.01% |
+6,105
| New | +$45.2K |
|
453
Foghorn Therapeutics
FHTX
$394M
| $49.8K | ﹤0.01% |
9,215
-694
| -7% | -$3.15K |
|
|
MENS
454
Jyong Biotech
MENS
$151M
| $48.9K | ﹤0.01% |
+12,389
| New | +$438K |
|
455
Puma Biotechnology
PBYI
$459M
| $48.9K | ﹤0.01% |
+8,211
| New | +$43.6K |
|
456
Neumora Therapeutics
NMRA
$317M
| $48.7K | ﹤0.01% |
27,227
-1,160
| -4% | -$2.54K |
|
457
Canadian Solar
CSIQ
$1.07B
| $47.5K | ﹤0.01% |
+2,000
| New | +$43.6K |
|
458
AMN Healthcare
AMN
$1.26B
| $47.3K | ﹤0.01% |
3,000
+2,000
| +200% | +$35.7K |
|
|
AARD
459
Aardvark Therapeutics
AARD
$144M
| $46.6K | ﹤0.01% |
+3,548
| New | +$44.3K |
|
460
Atea Pharmaceuticals
AVIR
$405M
| $45.5K | ﹤0.01% |
12,731
-1,179
| -8% | -$3.75K |
|
|
VALN
461
Valneva
VALN
$567M
| $44.1K | ﹤0.01% |
+5,000
| New | +$46.4K |
|
462
OmniAb
OABI
$497M
| $43.4K | ﹤0.01% |
23,457
+1,949
| +9% | +$3.39K |
|
|
CTNM
463
Contineum Therapeutics
CTNM
$564M
| $43K | ﹤0.01% |
+3,764
| New | +$42.9K |
|
464
Oculis Holding
OCS
$716M
| $39.9K | ﹤0.01% |
2,000
+1,000
| +100% | +$20K |
|
465
Orchestra BioMed
OBIO
$266M
| $38.2K | ﹤0.01% |
+9,201
| New | +$37.1K |
|
466
Voyager Therapeutics
VYGR
$197M
| $37.7K | ﹤0.01% |
9,603
-120
| -1% | -$531 |
|
467
Vor Biopharma
VOR
$1.21B
| $35.9K | ﹤0.01% |
+2,746
| New | +$51.1K |
|
468
iRhythm Holdings
IRTC
$4.13B
| $35.5K | ﹤0.01% |
200
-1,400
| -88% | -$248K |
|
469
Quantum-Si Incorporated
QSI
$182M
| $35.1K | ﹤0.01% |
+31,865
| New | +$51.9K |
|
470
Cabaletta Bio
CABA
$465M
| $34.4K | ﹤0.01% |
+15,686
| New | +$38.9K |
|
|
EVMN
471
Evommune Inc
EVMN
$512M
| $34.2K | ﹤0.01% |
+2,000
| New | +$37.6K |
|
472
Surrozen
SRZN
$284M
| $33.9K | ﹤0.01% |
1,500
+500
| +50% | +$8.09K |
|
|
UXIN
473
Uxin Ltd
UXIN
$249M
| $33.7K | ﹤0.01% |
+10,000
| New | +$29.9K |
|
474
Alpha Teknova
TKNO
$397M
| $33.1K | ﹤0.01% |
8,723
-657
| -7% | -$3.2K |
|
475
Editas Medicine
EDIT
$436M
| $32.6K | ﹤0.01% |
15,907
+145
| +0.9% | +$419 |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q4 2025 Portfolio in Review
As of Q4 2025, China Universal Asset Management Company held 543 positions worth $1.3B, up 7.6% from $1.21B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
China Universal Asset Management Company's Q4 2025 filing shows 63 new, 193 increased, 214 reduced and 47 closed positions. Its largest new stake was Western Digital: 13,175 shares worth $2.27M. The largest sale was Broadcom, an estimated $11.5M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Communication Services.
- China Universal Asset Management Company's largest Q4 2025 buy was Western Digital: 13,175 shares worth $2.27M.
- China Universal Asset Management Company added most to ProShares Ultra Gold in Q4 2025, an estimated $16.2M increase.
- China Universal Asset Management Company's biggest Q4 2025 reduction was Broadcom, cutting an estimated $11.5M.
- China Universal Asset Management Company fully exited Royal Caribbean in Q4 2025, selling an estimated $2.72M.
- China Universal Asset Management Company's ten largest holdings make up 36% of its $1.3B portfolio in Q4 2025.
- China Universal Asset Management Company opened 63 new positions and closed 47 in Q4 2025.
- China Universal Asset Management Company's portfolio value rose 7.6% quarter-over-quarter to $1.3B.
Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.